Sunway Healthcare Finalizes $722 Million IPO Price, Marking Malaysia’s Largest Stock Market Debut in Nearly a Decade

Sunway Healthcare sets its IPO price at 1.45 ringgit, aiming to raise $722 million in Malaysia's largest listing in nine years. Trading begins March 18.

By: AXL Media

Published: Mar 9, 2026, 8:20 AM EDT

Source: The information in this article was sourced from Channel News Asia

Sunway Healthcare Finalizes $722 Million IPO Price, Marking Malaysia’s Largest Stock Market Debut in Nearly a Decade - article image
Sunway Healthcare Finalizes $722 Million IPO Price, Marking Malaysia’s Largest Stock Market Debut in Nearly a Decade - article image

Record-Breaking Valuation and Pricing

In a significant milestone for the Southeast Asian capital markets, Sunway Healthcare confirmed on Monday that its final offering price has been fixed at 1.45 ringgit per share. This pricing aligns with the company's earlier prospectus and aims to raise approximately 2.86 billion ringgit ($722.22 million). According to financial analysts, this represents a major vote of confidence in Malaysia’s private healthcare sector, positioning the IPO as the largest the country has seen in nearly nine years.

Strategic Stake and Market Entry

The initial public offering comprises 1.97 billion shares available to both institutional and retail investors. This offering represents a 17.1% stake in the company, which is a key unit of the prominent Malaysian conglomerate, Sunway. The finalized pricing brings the total valuation of Sunway Healthcare to 16.7 billion ringgit. Shares are officially scheduled to commence trading on Bursa Malaysia on March 18, 2026.

Leading Private Healthcare Infrastructure

Sunway Healthcare has solidified its position as one of Malaysia’s premier private medical providers. As of January 2026, the group manages a total of 1,805 licensed beds. Its flagship facility, Sunway Medical Centre in Kuala Lumpur, currently stands as the largest private hospital in Malaysia. The capital raised from the IPO is expected to further bolster the group’s expansion plans and technological integration across its clinical portfolio.

Categories

Topics

Related Coverage